Bill > S1545

This bill requires the Massachusetts Department of Public Health to conduct a comprehensive review and produce a report on APOL1 (apolipoprotein L 1) gene variants, which are associated with an increased risk of end-stage renal disease (kidney failure). The report must include specific recommendations for raising awareness about APOL1, such as potential strategies for screening and genetic testing, an analysis of potential funding mechanisms to support expanded screening and testing in the state, and any other relevant information the department identifies as important. The department is mandated to submit this report to the state legislature's clerks and the joint committee on public health by December 31, 2026. APOL1 is a gene that, when certain variants are present, can significantly increase an individual's risk of developing serious kidney disease, making this review an important public health initiative to understand and address potential genetic health risks.

Budget and Finance, Health and Social Services

https://malegislature.gov/Bills/194/S1545